3872 results for «612»

Filter By

3872 results

DCB and latest DES technology for coronary interventions

22 May 2025 – From EuroPCR 2025

Explore the latest in drug-coated balloon (DCB) and drug-eluting stent (DES) technology for coronary interventions. Review predictors of angiographic outcomes, trial data comparing DCB and DES, and insights into treating calcified lesions and bifurcation disease with novel devices.

DCB and latest DES technology for coronary interventions

Challenging scenarios in the pulmonary system - Part 1

21 May 2025 – From EuroPCR 2025

This session presents challenging pulmonary system cases including high-risk and intermediate-high risk pulmonary embolism, complex congenital heart disease, and rare cardiac conditions. Understand critical management strategies for these uncommon but urgent scenarios.

Challenging scenarios in the pulmonary system - Part 1

Novelty in ACS diagnosis and treatment

22 May 2025 – From EuroPCR 2025

Discover novel diagnostic and therapeutic advances in acute coronary syndrome (ACS) management. This session covers innovative topics such as paclitaxel-coated balloon angioplasty safety in STEMI, the prognostic role of carbon monoxide, AI-based ECG prediction of infarct-related arteries, microcirculatory resistance indices in MINOCA, and real-world optical coherence...

Novelty in ACS diagnosis and treatment

Mitral abstracts session

22 May 2025 – From EuroPCR 2025

Examine critical mitral valve research through a series of abstracts focusing on mitral TEER outcomes. Topics include the impact of mitral valve complexity, prognostic significance of right atrial pressure, comparative analysis of degenerative versus functional mitral regurgitation, and validation of risk scores, providing valuable insights for...

Mitral abstracts session

Imaging makes it clear!

22 May 2025 – From EuroPCR 2025

Explore the critical role of intravascular imaging in interventional cardiology through real-world cases. This session highlights the value of intravascular ultrasound (IVUS) in avoiding unnecessary stenting in STEMI patients, the application of optical coherence tomography (OCT) in complex scenarios, and the management of calcified lesions with...

Imaging makes it clear!

Outcome prediction using artificial intelligence and meta-analysis

22 May 2025 – From EuroPCR 2025

This session presents outcome prediction advancements through artificial intelligence and meta-analysis in cardiology. Topics include AI-guided aortic stenosis risk stratification, predictors of periprocedural stroke after TAVI, patient-specific computer simulations for bicuspid TAVI, and enhancements in large language model accuracy using Heart Team simulation.

Outcome prediction using artificial intelligence and meta-analysis

Anatomy, physiology and clinical judgment: insights from contemporary strategies to guide PCI

22 May 2025 – From EuroPCR 2025

Discover contemporary strategies integrating anatomy, physiology, and clinical judgment to guide percutaneous coronary intervention (PCI). This session explores the impact of stress cardiovascular magnetic resonance in primary prevention, viability-guided PCI, and physiology-based decision-making including quantitative flow ratio (QFR). Learn about identifying patients at risk for major...

Anatomy, physiology and clinical judgment: insights from contemporary strategies to guide PCI

DCB in STEMI : why, when and how ?

22 May 2025 – From EuroPCR 2025

Explore the evolving role of drug-coated balloons (DCB) in the management of STEMI patients. This session covers practical approaches including primary PCI with DEB, unconventional solutions in urgent scenarios, and personalized treatment strategies especially in very young patients. Learn how DCB technology intersects with complex lesion...

DCB in STEMI : why, when and how ?

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

22 May 2025 – From EuroPCR 2025

Address challenging TAVI scenarios involving bicuspid anatomy and pure aortic regurgitation with insights from international experiences. This session compares treatment options in China and Germany, explores anatomical and disease differences, and reviews various TAVI devices through detailed case presentations and expert commentary.

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

Pharmacotherapy coronary interventions: new insights

22 May 2025 – From EuroPCR 2025

Stay abreast of new insights in pharmacotherapy for coronary interventions with a focus on optimizing patient outcomes. Topics include ticagrelor monotherapy in chronic coronary syndrome post-PCI, analysis of multiple events in high bleeding risk patients from the MASTER DAPT trial, effects of beta-blocker interruption in MI...

Pharmacotherapy coronary interventions: new insights

Contemporary outcomes of PCI patients

22 May 2025 – From EuroPCR 2025

Examine contemporary outcomes in PCI patients through a collection of studies addressing angiographic complication incidences, safety of same-day discharge post-complex PCI, age-related outcome impacts in TAVI patients, and comparative long-term antiplatelet strategies. The session also explores timing effects in routine versus off-hours PCI.

Contemporary outcomes of PCI patients

Updates on percutaneous treatment of pulmonary embolism

22 May 2025 – From EuroPCR 2025

Stay abreast of the latest advances in percutaneous treatment of pulmonary embolism. This session covers clinical outcomes with novel vacuum thrombectomy devices, mechanical thrombectomy registries, catheter-directed therapies in intermediate-high risk PE, and profiles of subacute PE interventions to inform optimal treatment strategies.

Updates on percutaneous treatment of pulmonary embolism

TAVI in bicuspid aortic valve disease

22 May 2025 – From EuroPCR 2025

Explore the unique challenges of TAVI in bicuspid aortic valve disease with a focus on long-term outcomes, residual gradients, prosthesis-patient mismatch, and anatomical subtype comparisons. This session draws on international registry data to inform clinical decision-making and optimize procedural strategies in this complex patient population.

TAVI in bicuspid aortic valve disease

Advanced tools for the diagnosis of coronary artery disease

22 May 2025 – From EuroPCR 2025

This session highlights advanced diagnostic tools for coronary artery disease, focusing on innovative pressure gradient assessments, computed tomography perfusion accuracy in stented patients, head-to-head comparisons of IQ-FFR with invasive FFR, and comprehensive evaluations of coronary physiology and plaque vulnerability derived from angiography.

Advanced tools for the diagnosis of coronary artery disease

Redo TAVI - How to treat different TAVI platforms when they fail

22 May 2025 – From EuroPCR 2025

Understand the complexities of redo TAVI procedures with emphasis on planning, valve platform characteristics, and tailored procedural strategies. This session features cases of redo TAVI for failed short-frame and tall-frame valves, alongside discussions on current evidence gaps guiding optimal management.

Redo TAVI - How to treat different TAVI platforms when they fail

High thrombus burden in STEMI

22 May 2025 – From EuroPCR 2025

This session addresses the management of high thrombus burden in STEMI patients. It reviews available tools and strategies for thrombus management, presents multiple case-based discussions illustrating treatment decisions, and explores the evolving role of thrombus aspiration in contemporary practice.

High thrombus burden in STEMI

Risk stratification of NSTEMI patients

22 May 2025 – From EuroPCR 2025

Explore the latest insights on risk stratification in NSTEMI patients through comparative analysis of established risk scores such as GRACE, HEART, and TIMI in predicting coronary artery disease severity. This session also reviews outcomes based on diabetes status and left ventricular ejection fraction, prospective validation of...

Risk stratification of NSTEMI patients

Which device for which patient: DES, BRS or DCB?

22 May 2025 – From EuroPCR 2025

This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.

Which device for which patient: DES, BRS or DCB?

Should STEMI treatment be related to specific clinical patient characteristics

22 May 2025 – From EuroPCR 2025

This session evaluates whether STEMI treatment should be tailored to specific clinical patient characteristics. It includes insights into STEMI management in very young patients, benefits of revascularisation of LAD non-culprit lesions in older AMI patients, clinical outcomes from the NAMI registry for young STEMI patients, and...

Should STEMI treatment be related to specific clinical patient characteristics

Understanding research: insights from a groundbreaking study

22 May 2025 – From EuroPCR 2025

Enhance your understanding of contemporary research in PCI versus CABG with this session. Learn foundational research principles, latest study findings, and how to translate evidence into clinical practice to improve patient communication and outcomes, bridging the gap between research and everyday cardiology care.

Understanding research: insights from a groundbreaking study
Didn’t find what you were looking for?